Memorial Sloan-Kettering Cancer Center Sleepy Hollow: Clinical Trials at Sleepy Hollow

Browse our continually updated listing of clinical trials available to patients at Memorial Sloan-Kettering Cancer Center Sleepy Hollow below. You can also explore our complete listing of clinical trials available at Memorial Sloan-Kettering.

Showing 21 - 40 of 75 trials
Title Investigatorsort icon Disease(s)
A Phase I/II Study of Temsirolimus, Paclitaxel, and Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer
[Protocol 09-131]
Fury, Matthew
  • Head & Neck Cancer
A Phase III Study of Sublobar Resection versus Stereotactic Body Radiation Therapy in High-Risk Patients with Stage I Non-Small Cell Lung Cancer
[Protocol 13-003]
Gelblum, Daphna
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
A Phase I/II Study of Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Patients with Relapsed/Refractory Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)
[Protocol 05-103]
Gerecitano, John
  • Leukemia
    • Chronic Lymphocytic Leukemia
  • Lymphoma
A Long-Term Study of Sexual and Reproductive Health in Women with Breast Cancer and Lymphoma
[Protocol 12-249]
Goldfarb, Shari
  • Breast Cancer
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
  • Survivorship
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Pancreatic Cancer
[Protocol 10-083]
Goodman, Karyn
  • Hepatobiliary
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Comprehensive Assessment to Predict Side Effects from Chemotherapy and an Evaluation of Pre-Phase Chemotherapy in Older Patients with Non-Hodgkin Lymphoma
[Protocol 13-028]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
[Protocol 11-107]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
[Protocol 12-018]
Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase III Study of Paclitaxel plus Carboplatin Versus Ifosfamide plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Persistent or Recurrent Carcinosarcoma of the Uterus
[Protocol 10-007]
Hensley, Martee
  • Endometrial and other Uterine Cancers
    • Uterine Cancer
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase III Study of Gemcitabine, Docetaxel, and Doxorubicin versus Observation in Women with High-Grade Uterine Leiomyosarcoma
[Protocol 12-177]
Hensley, Martee
  • Endometrial and other Uterine Cancers
    • Leiomyosarcoma
    • Uterine Cancer
  • Leiomyosarcoma
  • Sarcomas
    • Leiomyosarcoma
    • Soft Tissue Sarcoma
A Pilot Study of Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer Requiring Treatment of the Internal Mammary Lymph Nodes
[Protocol 10-025]
Ho, Alice
  • Breast Cancer
A Study of Physician Communication Skills to Promote Patients' Transition to Survivorship
[Protocol 11-180]
Horwitz, Steven
  • Lymphoma
  • Survivorship
A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgery in Patients with Locally Advanced Thymoma
[Protocol 09-038]
Huang, James
  • Thymoma
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131]
Hyman, David
  • Hematology
    • Hematologic Disorders
    • Multiple Myeloma
A Phase II Study of MLN8237 in Patients with Recurrent or Persistent Uterine Leiomyosarcoma
[Protocol 12-164]
Hyman, David
  • Endometrial and other Uterine Cancers
    • Leiomyosarcoma
    • Uterine Cancer
  • Leiomyosarcoma
  • Sarcomas
    • Leiomyosarcoma
    • Soft Tissue Sarcoma
A Phase II Study of PET Scan-Directed Combined Modality Therapy for Esophageal Cancer
[Protocol 12-011]
Ilson, David
  • Upper Gastrointestinal
    • Esophageal Cancer
A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer
[Protocol 06-103]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase III Study of Radiation Therapy with and without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
[Protocol 11-120]
Kaley, Thomas
  • Brain Tumors, Primary
    • Gliomas
  • Pediatric Brain Tumors
    • Brain Cancer
Early Onset and Familial Gastric Cancer Registry
[Protocol 05-118]
Kelsen, David
  • Hereditary Cancer & Genetics
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase II Study of Hepatic Arterial Infusion and Intravenous Chemotherapy with or without Panitumumab in Patients with Normal KRAS with Resected Liver Metastases from Colorectal Cancer
[Protocol 10-137]
Kemeny, Nancy
  • Colorectal Cancer